Abstract
We are proposing the use of pulmonary-proteoliposome as a new therapeutic approach for Coronaviruses. The designed strategy represents a potential treatment to reduce the overall viral load in the lungs and to help the immune system to successfully stave off the infection.
Keywords:
Coronavirus; SARS-COV-2; liposome.
MeSH terms
-
Angiotensin-Converting Enzyme 2
-
Betacoronavirus
-
COVID-19
-
Cell Membrane / metabolism
-
Coronavirus Infections / prevention & control*
-
Membranes, Artificial*
-
Pandemics / prevention & control*
-
Peptidyl-Dipeptidase A / metabolism*
-
Pneumonia, Viral / prevention & control*
-
Proteolipids / metabolism*
-
SARS-CoV-2
-
Spike Glycoprotein, Coronavirus / metabolism*
-
Viral Load
Substances
-
Membranes, Artificial
-
Proteolipids
-
Spike Glycoprotein, Coronavirus
-
proteoliposomes
-
spike protein, SARS-CoV-2
-
Peptidyl-Dipeptidase A
-
Angiotensin-Converting Enzyme 2